Substituted benzoxazinones and uses thereof

Details Substituted benzoxazinones and uses thereof Substituted benzoxazinones and uses thereof

2006-11-28

2006-11-28

Habte, Kahsay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S230500, C514S217050, C514S221000, C514S222500, C540S491000, C540S575000, C540S593000, C540S599000, C540S567000, C544S105000, C544S002000

Reexamination Certificate

active

07141562

ABSTRACT:
Compound of the Formula:and pharmaceutically acceptable salts or prodrugs thereof, wherein: X is CH or N, Y is C or S, Z is —SO2— or —(CRaRb)r—, n is 1 or 2, R2is aryl or heteroaryl, and R1, R3, R4, R5, R6, R7, R8, R9, Ra, Rb, m, p, q and r, are as defined herein. The compounds are modulators of the 5-HT6 receptor and are useful for treatment of central nervous system disorders. Also provided are methods for preparing, compositions comprising, and methods for using Compounds of Formula I.

REFERENCES:
patent: 5424313 (1995-06-01), Hartog et al.
patent: 6214829 (2001-04-01), Feenstra et al.
patent: 6225312 (2001-05-01), Feenstra et al.
patent: WO 97/36893 (1997-10-01), None
patent: WO 01/14330 (2001-03-01), None
patent: WO 01/57003 (2001-08-01), None
patent: WO 01/72725 (2001-10-01), None
patent: WO 02/02529 (2002-01-01), None
patent: WO 02/34754 (2002-05-01), None
patent: WO 03/095434 (2003-11-01), None
Russell MG and Dias R. (Curr. Top. Med. Chem, Jun. 2002; 2(6):643-54).
Thomas A. Godwin (Gastrointestinal Diseases, <http://edcenter.med.cornell.edu/CUMC—PathNotes/Gastrointestinal/Gastrointestinal.html>, 51 pages), downloaded on Jul. 7, 2005.
Belliotti, T.R., et al, “A Series of 6- and 7-Piperazinyl- and-Piperidinylmethylbenzoxazinones with Dopamine D4 Antagonist Activity: Discovery of a Potential Atypical Antipsychotic Agent”,J. Med. Chem,1999, 42(25), pp. 5181-5187.
Gutschow, M., et al, Studies on 2-benzyloxy-4H-3,1-benzoxazine-4-ones as serine protease inhibitors:,Pharmaceutica Acta Helvetiae,1999, 73(2), pp. 95-103.
Krantz, A., et al, “Design and Synthesis of 4H-3,1-Benzoxazine-4-ones as Potent Alternate Substrate Inhibitors of Human Leukocyte Elastase”,J. Med. Chem.,1990, 33(2), pp. 464-479.
Spencer, R.W., et al., “Inhibiton of Serine Proteases by Benzoxazinones: Effects of Electron Withdrawal and 5-Substitution”,Biochem Biophys Res. Commun,1986, 140(3), pp. 928-933.
Taverne, T., et al., “Novel Benzothiazolin-2-one and Benzoxazin-3-one-Arylpiperazine Derivatives with Mixed 5HT1A/D2Affinity as Potential Atypical Antipsychotics”,J. Med Chem,1998, 41(12), pp. 2010-2018.
Feenstra, Rolf W. et al., “New 1-Aryl-4-(biarylmethylene)piperazines as Potential Atypical Antipsychotics Sharing Dopamine D2-Receptor and Serotonin 5-HT1A-Receptor Affinities,”Bioorganic&Medicinal Chemistry Letters,(2001) pp. 2345-2349, No. 11, Pergamon.

Affiliated with

Also associated with

Rating

Substituted benzoxazinones and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted benzoxazinones and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoxazinones and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3637117